The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...

Spontaneity is out the window when MS is involved, so it's the little things that impact a relationship, writes columnist Be.

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

Columnist Desiree Lama describes her journey with MS-related bladder problems that were brought under control but are now ...

Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

An all-new, physician-led multiple sclerosis (MS) video series designed to encourage and inspire you through expert insights, ...

MS patient Lynda Whitton received MS Australia’s 2024 John Studdy Award in recognition of her advocacy, leadership, and ...

Less frequent Ocrevus infusions are just as effective in controlling MS, but may help limit the risk of side effects, per a ...

Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

Severe obesity in childhood and adolescence more than triples the risk of MS, and obesity treatment does not seem to reverse ...